SATB2 and neoplasm: These alterations converge into increased tumorigenicity, sustained proliferation and enhanced metastatic potential [24]. In addition, SATB2-AS1 is specifically involved in the PI3K-Akt signaling pathway, which can affect the epithelial–mesenchymal transition in numerous ways to influence tumor aggressiveness [38].